|
Market Closed -
Nasdaq
01:30:00 04/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 151.22 USD | +1.08% |
|
+1.59% | +23.20% |
| 03/09 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 01/09 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 19TCr | - | ||||
| 1,03400Cr | |||||
| 67TCr | - | - | - | ||
| 46TCr | |||||
| 35TCr | |||||
| 31TCr |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
